These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 20550063

  • 1. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M, Vergaro G, Giannoni A, Passino C.
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract] [Full Text] [Related]

  • 2. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 3. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 6. New concepts in post-infarction ventricular remodeling.
    Udelson JE, Patten RD, Konstam MA.
    Rev Cardiovasc Med; 2003 Nov 16; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z, Rogers JG.
    Curr Opin Cardiol; 2009 May 16; 24(3):223-9. PubMed ID: 19318933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW, Alexander KP.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract] [Full Text] [Related]

  • 12. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS.
    J Lab Clin Med; 2001 May 09; 137(5):316-23. PubMed ID: 11329528
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan 09; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 15. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ.
    Eur Heart J; 1998 Jun 09; 19 Suppl F():F62-71. PubMed ID: 9651738
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT, Greenberg BH, Yancy CW.
    Am J Cardiol; 2008 Sep 08; 102(5A):21G-28G. PubMed ID: 18722188
    [Abstract] [Full Text] [Related]

  • 17. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X, Saini HK, Wang J, Gupta SK, Goyal RK, Dhalla NS.
    Expert Rev Cardiovasc Ther; 2005 Jul 08; 3(4):717-32. PubMed ID: 16076281
    [Abstract] [Full Text] [Related]

  • 18. The use of beta-blockade therapy in treatment of congestive heart failure.
    Sobotka PA, Gunnar RM.
    Clin Cardiol; 1992 Sep 08; 15(9):630-5. PubMed ID: 1356677
    [Abstract] [Full Text] [Related]

  • 19. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I, Liu P, Webb G.
    Int J Cardiol; 2004 Dec 08; 97 Suppl 1():25-33. PubMed ID: 15590076
    [Abstract] [Full Text] [Related]

  • 20. [Molecular pathogenesis of heart failure].
    Maier LS.
    Dtsch Med Wochenschr; 2006 Mar 10; 131(10):503-5. PubMed ID: 16511741
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.